Recent Advances and Clinical Outcomes of Kidney Transplantation Volume 2

Advances in immunosuppression and kidney transplant techniques have led to significant improvements in the short-term survival of the renal allograft. Long-term graft survival, however, has relatively lagged behind and has now become one of the main problems in kidney transplantation. In this Specia...

Full description

Saved in:
Bibliographic Details
Other Authors: Cheungpasitporn, Wisit (Editor), Thongprayoon, Charat (Editor), Leeaphorn, Napat (Editor)
Format: Electronic Book Chapter
Language:English
Published: Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute 2020
Subjects:
age
BKV
n/a
GFR
Online Access:DOAB: download the publication
DOAB: description of the publication
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000naaaa2200000uu 4500
001 doab_20_500_12854_69055
005 20210501
003 oapen
006 m o d
007 cr|mn|---annan
008 20210501s2020 xx |||||o ||| 0|eng d
020 |a books978-3-03936-408-4 
020 |a 9783039364077 
020 |a 9783039364084 
040 |a oapen  |c oapen 
024 7 |a 10.3390/books978-3-03936-408-4  |c doi 
041 0 |a eng 
042 |a dc 
072 7 |a M  |2 bicssc 
100 1 |a Cheungpasitporn, Wisit  |4 edt 
700 1 |a Thongprayoon, Charat  |4 edt 
700 1 |a Leeaphorn, Napat  |4 edt 
700 1 |a Cheungpasitporn, Wisit  |4 oth 
700 1 |a Thongprayoon, Charat  |4 oth 
700 1 |a Leeaphorn, Napat  |4 oth 
245 1 0 |a Recent Advances and Clinical Outcomes of Kidney Transplantation  |b Volume 2 
260 |a Basel, Switzerland  |b MDPI - Multidisciplinary Digital Publishing Institute  |c 2020 
300 |a 1 electronic resource (270 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
506 0 |a Open Access  |2 star  |f Unrestricted online access 
520 |a Advances in immunosuppression and kidney transplant techniques have led to significant improvements in the short-term survival of the renal allograft. Long-term graft survival, however, has relatively lagged behind and has now become one of the main problems in kidney transplantation. In this Special Issue, we discuss the recent research developments in kidney transplants that may affect long-term allografts, as well as the survival of the patient. The latest developments in living kidney donation are also explored. 
540 |a Creative Commons  |f https://creativecommons.org/licenses/by/4.0/  |2 cc  |4 https://creativecommons.org/licenses/by/4.0/ 
546 |a English 
650 7 |a Medicine  |2 bicssc 
653 |a malondialdehyde 
653 |a oxidative stress 
653 |a new-onset diabetes 
653 |a renal transplantation 
653 |a BK virus 
653 |a BK virus nephropathy 
653 |a kidney allograft 
653 |a transplantation 
653 |a Alport syndrome 
653 |a children 
653 |a autosomal dominant polycystic kidney disease 
653 |a epidemiology 
653 |a hospitalization 
653 |a kidney transplantation 
653 |a subarachnoid hemorrhage 
653 |a malignancy 
653 |a post-transplant malignancy 
653 |a renal cell carcinoma 
653 |a meta-analysis 
653 |a systematic reviews 
653 |a tacrolimus 
653 |a C/D-ratio 
653 |a pharmacokinetics 
653 |a opportunistic infection 
653 |a allograft survival 
653 |a urological complications 
653 |a ureteric stent 
653 |a urinary tract infection 
653 |a timing of removal 
653 |a living donor 
653 |a ethnicity 
653 |a age 
653 |a obesity 
653 |a genetic relationship donor/recipient 
653 |a atypical hemolytic uremic syndrome 
653 |a eculizumab 
653 |a glucose intolerance 
653 |a insulin secretion 
653 |a insulin resistance 
653 |a oral glucose tolerance test 
653 |a healthy subject 
653 |a hyperchloremia 
653 |a kidney graft dysfunction 
653 |a living donor kidney transplantation 
653 |a Uropathogenic E. coli 
653 |a UPEC 
653 |a phylogeny 
653 |a genomics 
653 |a antibiotic resistance 
653 |a virulence traits 
653 |a night-time renal transplantation 
653 |a graft survival 
653 |a patient survival/outcome 
653 |a surgical complications 
653 |a acute rejection 
653 |a lymphocyte 
653 |a CD45RC 
653 |a Belatacept 
653 |a cardiovascular high risk 
653 |a outcome 
653 |a machine perfusion 
653 |a organ preservation 
653 |a temperature 
653 |a hypothermic 
653 |a normothermic 
653 |a transplant 
653 |a proton-pump inhibitors 
653 |a iron 
653 |a iron deficiency 
653 |a polyomavirus 
653 |a BKV 
653 |a kidney 
653 |a glomerulus 
653 |a BKVAN 
653 |a nephropathy 
653 |a fluid management 
653 |a delayed graft function 
653 |a goal-directed fluid therapy 
653 |a calcineurin inhibitor nephrotoxcity 
653 |a C/D ratio 
653 |a tacrolimus metabolism 
653 |a ADPKD 
653 |a native nephrectomy 
653 |a patient outcome 
653 |a perioperative complications 
653 |a epidermal growth factor 
653 |a creatinine 
653 |a graft failure 
653 |a renal transplantation. 
653 |a new onset diabetes after renal transplantation 
653 |a single nucleotide polymorphisms 
653 |a n/a 
653 |a urinary biomarkers 
653 |a α-GST 
653 |a π-GST 
653 |a nephrotoxicity 
653 |a urinary excretion of N1-methylnicotinamide 
653 |a mortality 
653 |a niacin status 
653 |a dietary intake 
653 |a tryptophan 
653 |a vitamin B3 
653 |a Kidney transplant 
653 |a vitamin C 
653 |a cancer mortality 
653 |a oxidative stress. 
653 |a mycophenolic acid 
653 |a immunosuppression 
653 |a plasmapheresis 
653 |a oxalate 
653 |a hyperoxaluria 
653 |a kidney transplant recipients 
653 |a post-transplantation diabetes mellitus 
653 |a all-cause mortality 
653 |a cardiovascular mortality 
653 |a infectious mortality 
653 |a magnesium 
653 |a hypomagnesaemia 
653 |a cancer 
653 |a kidney transplant 
653 |a survival 
653 |a living kidney donation 
653 |a living-donor kidney transplantation 
653 |a beliefs 
653 |a inequity 
653 |a ischemia reperfusion injury 
653 |a innate immune system 
653 |a adaptive immune system 
653 |a apoptosis 
653 |a necrosis 
653 |a hypoxic inducible factor 
653 |a endothelial dysfunction 
653 |a proton pump inhibitor 
653 |a transplant rejection 
653 |a GFR 
653 |a insulin-like growth factor 1 
653 |a growth hormone 
653 |a muscle mass 
653 |a patient survival 
653 |a physical activity 
653 |a renal transplant recipients 
653 |a kidney transplant (KT) 
653 |a donor-specific antibodies (DSA) 
653 |a C3d-binding assay 
653 |a antibody-mediated rejection (AMR) 
653 |a arsenic 
653 |a diet 
653 |a fish consumption 
653 |a post-transplant diabetes mellitus 
653 |a N1-methyl-2-pyridone-5-carboxamide 
653 |a N1-methylnicotinamide 
653 |a urinary excretion 
653 |a kidney function 
653 |a biomarker 
653 |a branched chain amino acids 
653 |a posttransplant diarrhea 
653 |a methanogenesis 
653 |a Methanosphaera stadtmanae 
653 |a mucins 
653 |a sulfate-reducing bacteria 
653 |a acute humoral rejection 
653 |a first-line therapy 
653 |a outcomes 
653 |a proteasome inhibitor 
653 |a renal transplant 
653 |a transplant recipients 
653 |a calcineurin inhibitors 
653 |a FK506 
653 |a pharmacokinetic 
653 |a fast tacrolimus metabolizers 
856 4 0 |a www.oapen.org  |u https://mdpi.com/books/pdfview/book/2824  |7 0  |z DOAB: download the publication 
856 4 0 |a www.oapen.org  |u https://directory.doabooks.org/handle/20.500.12854/69055  |7 0  |z DOAB: description of the publication